Search
Products
Community
Markets
Brokers
More
IN
Get started
Markets
/
/
AZN/N
A
A
ASTRAZENECA PLC
AZN/N
Mexican Stock Exchange
AZN/N
Mexican Stock Exchange
AZN/N
Mexican Stock Exchange
AZN/N
Mexican Stock Exchange
Market closed
Market closed
1,490.00
MXN
D
−39.00
−2.55%
At close at Apr 3, 15:22 GMT
MXN
No trades
See on Supercharts
Overview
Financials
News
Discussions
Technicals
Forecast
Seasonals
Bonds
AZN/N
chart
Full chart
1 day
0.00%
5 days
1.26%
1 month
0.07%
6 months
−1.35%
Year to date
14.42%
1 year
36.52%
5 years
42.70%
All time
532.47%
AZN/N upcoming
earnings
Next report date
April 29
Report period
Q1 2025
EPS estimate
22.63
MXN
Revenue estimate
282.02 B
MXN
Key
stats
Market capitalization
4.58 T
MXN
Dividend yield (indicated)
2.10%
Price to earnings Ratio (TTM)
33.53
Basic EPS (TTM)
47.32
MXN
Net income (FY)
146.68 B
MXN
Revenue (FY)
1.13 T
MXN
Shares float
3.10 B
Beta (1Y)
0.11
About ASTRAZENECA PLC ORD USD0.25
Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Pascal Soriot
Website
astrazeneca.co.uk
Headquarters
Cambridge
Founded
1992
FIGI
BBG000C28SY4
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Show more
Financials
Performance
Annual
Annual
Quarterly
Quarterly
More
More
7.5%
10.0%
12.5%
15.0%
17.5%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
80.00 B
160.00 B
240.00 B
320.00 B
Revenue
Net income
Net margin %
Revenue to profit
conversion
Annual
Annual
Quarterly
Quarterly
More
More
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
0.00
80.00 B
160.00 B
240.00 B
320.00 B
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
0.00
80.00 B
160.00 B
240.00 B
320.00 B
Debt level and
coverage
Annual
Annual
Quarterly
Quarterly
More
More
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
0.00
160.00 B
320.00 B
480.00 B
640.00 B
Debt
Free cash flow
Cash & equivalents
Earnings
Next:
Apr 29, 2025
Annual
Annual
Quarterly
Quarterly
More
More
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
0.00
6.00
12.00
18.00
24.00
Actual
Estimate
AZN/N
news
No news here
Looks like there's nothing to report right now
Reload
Technicals
Summarizing what the indicators are
suggesting.
Neutral
Sell
Buy
Strong sell
Strong buy
Strong sell
Sell
Neutral
Buy
Strong buy
Neutral
Sell
Buy
Strong sell
Strong buy
Strong sell
Sell
Neutral
Buy
Strong buy
Neutral
Sell
Buy
Strong sell
Strong buy
Strong sell
Sell
Neutral
Buy
Strong buy
Analyst
rating
An aggregate view of professional's
ratings.
Neutral
Sell
Buy
Strong sell
Strong buy
Strong sell
Sell
Neutral
Buy
Strong buy
Neutral
Sell
Buy
Strong sell
Strong buy
Strong sell
Sell
Neutral
Buy
Strong buy
Neutral
Sell
Buy
Strong sell
Strong buy
Strong sell
Sell
Neutral
Buy
Strong buy
Seasonals
Displays a symbol's price movements over previous years to identify recurring trends.
AZN/N highest yielding
bonds
US46353AX6
ASTRAZENECA 20/50
Yield to maturity
6.86%
Maturity date
Aug 6, 2050
US46353AZ1
ASTRAZENECA 21/51
Yield to maturity
6.22%
Maturity date
May 28, 2051
US46353AU2
ASTRAZENECA 18/48
Yield to maturity
5.73%
Maturity date
Aug 17, 2048
US46353AM0
ASTRAZENECA PLC 15/45
Yield to maturity
5.70%
Maturity date
Nov 16, 2045
AZN3901525
AstraZeneca PLC 4.0% 18-SEP-2042
Yield to maturity
5.67%
Maturity date
Sep 18, 2042
AZN.GE
AstraZeneca PLC 6.45% 15-SEP-2037
Yield to maturity
4.80%
Maturity date
Sep 15, 2037
US46353AW8
ASTRAZENECA 20/30
Yield to maturity
4.75%
Maturity date
Aug 6, 2030
A
US4636NAN3
ASTRAZEN.FI. 24/34
Yield to maturity
4.72%
Maturity date
Feb 26, 2034
A
AZN5193314
AstraZeneca Finance LLC 2.25% 28-MAY-2031
Yield to maturity
4.71%
Maturity date
May 28, 2031
A
AZN5549116
AstraZeneca Finance LLC 4.875% 03-MAR-2033
Yield to maturity
4.59%
Maturity date
Mar 3, 2033
50UC
ASTRAZENECA PLC 5.75% SNR EMTN 13/11/2031
Yield to maturity
4.54%
Maturity date
Nov 13, 2031
See all AZN/N bonds
Sparks
Curated watchlists where AZN/N is featured.
Big pharma stocks: Top pharmaceutical firms
Biotech stocks: A shot in the arm
Covid vaccine stocks: Jabtastic
UK stocks: Best of British
28
No. of Symbols
See all sparks